S t r a u b E n d o v a s c u l a r S y s t e m&

S t r a u b E n d o v a s c u l a r To o l sS t r a u b E n d o v a s c u l a r To o l sFor

professional use only

S t r a u b E n d o v a s c u l a r S y s t e mEffect ive debu lk ing in occ luded ar ter ies and ve ins

E f f e c t i v e d e b u l k i n g i n m u l t i p l e i n d i c a t i o n s 1

Detachment up to 1cm/sec.

O n e d e v i c e f o r a c u t e , s u b a c u t e a n d c h r o n i c a r t e r i a l o c c l u s i o n s o f N a t i v e v e s s e l s

S t e n t s ( I n - s t e n t o c c l u s i o n )

N a t i v e a n d a r t i f i c i a l b y p a s s e s

D i a l y s i s a c c e s s

Fo u r f u n c t i o n s i n o n e d e v i c e

Detachment o f the occ lud ing mater ia l f rom the vesse l (up to 1 cm/sec)

Asp i rat ion o f detached mater ia l in to the catheter head

Fragmentat ion o f the asp i ra ted mater ia l

Transpor tat ion out of the pat ient`s body

++++

+

+

++

1 Freitas B, Steiner S, Bausback Y, Branzan D, Ulrich M, Bräunlich S, Schmidt A, Scheinert D. Rotarex®S Mechanical Debulking in Acute and Subacute Arterial Lesions: Single-Center Experience with 525 Patients. Angiology. 2016 May; 18[3]:233–241.

Rot

a rex

® S 8FRo t

a rex

® S 1 0

F

TM

TM

TM

C a s e r e p o r t Dr. Sven Bräun l i ch , D iakon iekrankenhaus, Ha l le , Germany

CTO left SFA + DCB

8F Rotarex®S 1 70-year o ld pat ient w i th a c laud icat ion for one year of the le f t ca l f, wa lk ing d is t rance of 100 meters . Puncture of the r ight gro in prov ided a c ross-over approach to the SFA occ lus ion wh ich was recana l i sed with a wire intra luminal ly. Several passes with the Rotarex ®S 8F catheter fo l lowed by two DCB demonstrated restored f low. The pat ient remains symptom-f ree a f ter 12 months .

First passage Several passages

After DCB Result after 12 months 1 Data on �le at Straub Medical AG

E f f i c i e n t t h r o m b e c t o m y / e m b o l e c t o m y i n m a n y i n d i c a t i o n s 1

A c u t e o c c l u s i o n s o f Ve i n s

A r t e r i e s

D i a l y s i s a c c e s s

T h r e e f u n c t i o n s i n o n e d e v i c e A s p i r a t i o n o f f r e s h t h r o m b u s a n d e m b o l u s

Fr a g m e n t a t i o n o f a s p i r a t e d m a t e r i a l

Tr a n s p o r t a t i o n o u t o f t h e p a t i e n t ` s b o d y

+++

+++

Strong & continuous aspiration

1 Lichtenberg M. Improved clinical outcomes – Evidence on mechanical thrombectomy followed by stenting. Results presented LINC 2017.

Asp

i rex

® S 8F

Asp

i rex

® S 6F

Asp

i rex

® S 1 0

F

TM

TM

TM

C a s e r e p o r t Dr. M ichae l L ichtenberg , Karo l inen Hosp i ta l , Arnsberg , Germany

Recana l i zat ion of an acute i l iofemora l deep ve in thrombos is

us ing the Asp i rex ®S 10F catheter 1

41-year-old female with acute painful swelling of the left lower calf for two days. CT venography shows a descending

thrombus from distal inferior vena cava to the level of the left external iliac vein (Figure 1).

Intervention

Access was gained through an antegrade puncture of the

femoral vein under ultrasound guidance. With a 10F sheath

5000 units of heparin were administered. The first angiogram

demonstrated the complete thrombotic occlusion of the left

iliac vein (Figure 2). The external and common iliac veins were

passed with an angled 5F catheter over a stiff guide wire. The

guide wire was then exchanged to a 0.025” guide wire provided

for performing mechanical thrombectomy with the 10F

Aspirex®S system. After 3 passes with the Aspirex®S catheter a

quite effective outflow of the iliac vein (Figure 3) was

restored.

Following thrombectomy, venography demonstrated a

high-grade stenosis of the proximal common iliac vein, a site

typical for May-Thurner syndrome. Pre-dilatation of the

stenosis with a 14 x 60 mm PTA balloon was followed by stent

implantation with a 16 x 20 mm self-expanding venous stent.

Post-dilatation venogram showed optimal stent deployment

and wall apposition (Figure 4).

Post-intervention, vitamin K antagonist was prescribed as an

anticoagulation therapy for a period of 6 months. At the 3

month clinical follow-up the patient presented symptom-free.

Venous outflow was shown to be patent on the treated side

with no in-stent restenosis seen on duplex ultrasound.

Figure 2Figure 1

Figure 4Figure 3

1 Data on �le at Straub Medical AG

DRIVE SYSTEM

T h e s y s t e m f o r a l l R o t a r e x ® S a n d A s p i r e x ® S c a t h e t e r s

S i m p l e s e t u p

H a n d o r f o o t s w i t c h o p e r a t e d

M a g n e t i c c o u p l i n g t o c a t h e t e r

R o b u s t a n d s a f e

++

++

S i m p l e a n d s a f e o p e r a t i o n

S t r a u b E n d o v a s c u l a r T o o l sThe compan ions for your da i ly work

P u l m o n a r y E m b o l i s m P r o t e c t i o n

S e l f - e x p a n d i n g N i t i n o l B a s k e t

I m m e d i a t e r e t r i e v a l a f t e r i n t e r v e n t i o n

+ S e l f - e x p a n d i n g N i t i n o l B a s k e t S e l f - e x p a n d i n g N i t i n o l B a s k e t+ I m m e d i a t e r e t r i e v a l a f t e r i n t e r v e n t i o n I m m e d i a t e r e t r i e v a l a f t e r i n t e r v e n t i o n+

CAPTUREX

P e r i - i n t e r v e n t i o n a l F i l t e r C a t h e t e r

The safety net for

your endovascular interventions

GUIDEWIRE

S h a f t :

N i t i n o l co re w i t h P T F E co a t i n g

T i p :

F l ex i b l e a n d a n g l e d to fa c i l i t a te l e s i o n c ro s s i n g

G o l d - p l a te d t u n g s te n co i l fo r e a s i e r v i s u a l i s a t i o n

H yd ro p h i l i c co a t i n g to re d u ce f r i c t i o n s

++

+

+

T h e w i r e f o r e v e r y d a y

Straub Medical AGStraubstrasse 12CH-7323 WangsSwitzerland

Phone: +4 1 8 1 720 04 60Fax: +4 1 8 1 720 04 6 1E-Mail: info@straubmedical.comInternet: www.straubmedical.com ZE

106

62

A9

EN

D i s t r i b u te d by

Rotarex®, Aspirex®, Capturex® and Straub® are registered trademarks of Straub Medical AG in several countries. Word marks, picture marks and 3D marks are covered under the Trademark ™.

Rotarex®S TM

REF Catheter Sets Size LengthnumberREF 802 1 9 SET Rotarex®S 6F 1 1 0 cm

REF 80202 SET Rotarex®S 6F 135 cm

REF 80223 SET Rotarex®S 8F 85 cm

REF 80224 SET Rotarex®S 8F 1 1 0 cm

REF 80277 SET Rotarex®S 10F 85 cm

GuidewireREF Dimension Length Tip Flex Hydrophil ic Packagingnumber configuration Tip coatingREF 80270 Guidewire 0.0 1 8 “ 220 cm angled 40 mm 9.5 cm Pack of 5

REF 8027 1 Guidewire 0.0 1 8 “ 270 cm angled 40 mm 9.5 cm Pack of 5

REF 80272 Guidewire 0.0 1 8 “ 320 cm angled 40 mm 9.5 cm Pack of 5

REF 80304 Guidewire 0.025 “ 220 cm angled 60 mm 8.5 cm Pack of 5

REF 80305 Guidewire 0.025 “ 270 cm angled 60 mm 8.5 cm Pack of 5

Drive SystemREF 80300 Drive System

Capturex®

REF 80275 Capturex® SET

S E T i n c l u d es ca t h ete r, g u i d ew i re , s te r i l e d ra p e a n d co l l e c t i n g b a g

S E T i n c l u d es f i l te r ca t h ete r a n d d e l i ve r y s h ea t h

Aspirex®S TM

REF Catheter Sets Size LengthnumberREF 80226 SET Aspirex®S 6F 1 1 0 cm

REF 80227 SET Aspirex®S 6F 135 cm

REF 80229 SET Aspirex®S 8F 85 cm

REF 80230 SET Aspirex®S 8F 1 1 0 cm

REF 80232 SET Aspirex®S 10F 1 1 0 cm

2019

© C

opyr

ight

Str

aub

Med

ical

AG.

All

righ

ts re

serv

ed.

TM

TM